Jiangxia Cai
Impact in
-
- Traditional Chinese Medicine Analysis
-
- Antibiotic Resistance in Bacteria
Papers in
-
- Histone Deacetylase Inhibitors Research 3
- Ubiquitin and proteasome pathways 2
- Epigenetics and DNA Methylation 1
- Oncology 7
- Drug Transport and Resistance Mechanisms 6
- Cancer Treatment and Pharmacology 2
- Co-authors
- Yalin Dong (11 shared papers)Jianfeng Xing (9 shared papers)Weipeng Zhang (8 shared papers)Siying Chen (8 shared papers)Sasa Hu (7 shared papers)Jun Lü (7 shared papers)Xiaowei Zheng (7 shared papers)Haisheng You (3 shared papers)
- Journals
- Phytomedicine (2 papers)International Journal of Oncology (2 papers)Cancer Biology & Therapy (1 paper)Molecular BioSystems (1 paper)Medicine (1 paper)
- Partner nations
- ChinaUnited StatesIsrael
In The Last Decade
Jiangxia Cai
12 papers receiving 374 citations
Peers
Comparison fields: 5 of 62
- Complementary and alternative medicine 60
- Molecular Medicine 30
- Cancer Research 66
- Oncology 93
- Molecular Biology 181
Countries citing papers authored by Jiangxia Cai
This map shows the geographic impact of Jiangxia Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangxia Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangxia Cai more than expected).
Fields of papers citing papers by Jiangxia Cai
This network shows the impact of papers produced by Jiangxia Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangxia Cai. The network helps show where Jiangxia Cai may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiangxia Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 71 | |
| 2 | 2014 | 51 | |
| 3 | 2015 | 50 | |
| 4 | 2013 | 44 | |
| 5 | 2013 | 40 | |
| 6 | 2012 | 36 | |
| 7 | 2014 | 28 | |
| 8 | 2013 | 25 | |
| 9 | 2016 | 12 | |
| 10 | 2017 | 8 | |
| 11 | 2014 | 7 | |
| 12 | 2021 | 5 |
About Jiangxia Cai
Jiangxia Cai is a scholar working on Molecular Biology, Oncology, Cancer Research, Surgery and Pathology and Forensic Medicine, having authored 12 papers that have together received 377 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (6 papers), Histone Deacetylase Inhibitors Research (3 papers), Ubiquitin and proteasome pathways (2 papers), Cancer Treatment and Pharmacology (2 papers), Cancer, Lipids, and Metabolism (2 papers), Cancer Mechanisms and Therapy (1 paper), Epigenetics and DNA Methylation (1 paper) and Microtubule and mitosis dynamics (1 paper). The work is most often cited by research in Complementary and alternative medicine (60 citations), Molecular Medicine (30 citations), Cancer Research (66 citations), Oncology (93 citations) and Molecular Biology (181 citations). Jiangxia Cai has collaborated with scholars based in China, United States and Israel. Frequent co-authors include Yalin Dong, Jianfeng Xing, Weipeng Zhang, Siying Chen, Sasa Hu, Jun Lü, Xiaowei Zheng, Haisheng You, Jiao Xie and Siying Chen. Their work appears in journals such as Phytomedicine, International Journal of Oncology, Cancer Biology & Therapy, Molecular BioSystems and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.